Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours Β· Estimated delivery Aug 7 - Aug 12
For individuals struggling with type 2 diabetes , Wegovy offers a dual benefit
The primary outcome was the change in MDS-UPDRS Part 3 scores
Adults with a body mass index (BMI) of 30 or greater Adults with a BMI of 27 or greater who also have one weight-related condition, such as type 2 diabetes, high blood pressure, or high cholesterol Wegovy and Saxenda are also approved for the treatment of children age 12 and older
Bloating, gas, abdominal cramping, and nausea also occur frequently
A Medical Approach to Weight Management Our program is led by licensed providers and designed around your health history, goals, and needs
We also highlight why patients are turning to these medications and how Continental Hospitals can support you with expert care
US$ 24.21
US$ 25.46
US$ 20.80
US$ 25.04
